Emergent Product Development Seattle LLC clinical trials
Formerly part of Emergent BioSolutions, Aug 1, 2016 · source ↗
The registry lists 1 studies whose lead sponsor is Emergent Product Development Seattle LLC. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 26, 2012.
Before and after it left Emergent BioSolutions
- First submitted before Emergent Product Development Seattle LLC left Emergent BioSolutions
- 1
- First submitted after Emergent Product Development Seattle LLC left Emergent BioSolutions
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Emergent Product Development Seattle LLC1 study
Something wrong with this grouping? Tell us on the Emergent BioSolutions page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Emergent BioSolutions studies →
- Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary SyndromeTerminatedNCT00127881Phase 3
Sponsor listed in the registry: Emergent Product Development Seattle LLC · First submitted before Emergent Product Development Seattle LLC left Emergent BioSolutions